Leigh A. Kotze
Cape Town, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies.
Journal: Expert opinion on pharmacotherapy
Published: May 22, 2025
Agent-based model predicts that layered structure and 3D movement work synergistically to reduce bacterial load in 3D in vitro models of tuberculosis granuloma.
Journal: PLoS computational biology
Published: October 24, 2023
Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients.
Journal: Frontiers in immunology
Published: February 25, 2022
Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology.
Journal: International journal of molecular sciences
Published: February 21, 2022
Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases.
Journal: Frontiers in immunology
Published: December 20, 2021
Inhaled particulate matter affects immune responsiveness of human lung phagocytes to mycobacteria.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: July 21, 2021
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.
Journal: The Lancet. Infectious diseases
Published: July 06, 2021
Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis.
Journal: Cellular immunology
Published: March 24, 2021
Isolation and Functional Characterization of Myeloid-Derived Suppressor Cells in Infections Under High Containment.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 25, 2020
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.
Journal: The Journal of clinical investigation
Published: May 19, 2020
Last Updated: 09/26/2026